Glovista Investments LLC Amgen Inc Transaction History

Glovista Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $134,119 - $163,468	-594 Reduced 8.41%	6,468 $1.56 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $10,764 - $13,677	-47 Reduced 0.66%	7,062 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $13,018 - $14,682	-58 Reduced 0.81%	7,109 $1.6 Million
Q2 2022 Aug 16, 2022	SELL	$230.71 - $256.74 $5,537 - $6,161	-24 Reduced 0.33%	7,167 $1.74 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.58 Million - $1.74 Million	7,191 New	7,191 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $198,204 - $236,025	-916 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $247,064 - $303,182	-1,249 Reduced 57.69%	916 $216,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $227,617 - $301,883	1,249 Added 136.35%	2,165 $439,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $173,316 - $222,771	916 New	916 $221,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Glovista Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Glovista Investments LLC with notifications on news.